This inventor holds 21 USPTO granted patents, primarily in Cytokine Engineering. Top assignees: Chiron Corporation, Cetus Oncology Corporation, Cytel Corporation. Active years: 1994-2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ambler, PA (US) (1997)
- San Francisco, CA (US) (1994 - 2000)
- Rancho Santa Fe, CA (US) (1998 - 2000)
- Rancho Sante Fe, CA (US) (1998 - 2003)
- late of Rancho Sante Fe, CA (US) (2003)
Company Filing History:
15 out of 672 
4 out of 28 
2 out of 34 Years Active: 1994-2003
Areas of Expertise:
Title: Michael Kriegler: Innovator in Recombinant Proteins
Introduction
Michael Kriegler, based in San Francisco, CA, is a renowned inventor recognized for his significant contributions to biotechnology. With an impressive portfolio of 21 patents, he has played a pivotal role in advancing the field, particularly in the development of recombinant proteins used for medical applications.
Latest Patents
Among his latest patents are innovative methods and materials for producing purified, active recombinant human neutrophil protease, known as PR-3. These patents detail the activation of a pro-form referred to as proPR-3, facilitating the discovery of inhibitors that prevent the excessive release of mature, active TNFα. His research not only focuses on the production of recombinant PR-3 but also explores methodologies for identifying inhibitors that convert the pro-form of TNFα into its active state.
Career Highlights
Michael Kriegler has had a distinguished career, working with prominent companies such as Chiron Corporation and Cetus Oncology Corporation. His experience in these leading biotech firms has greatly enhanced his expertise in the field, enabling him to contribute to groundbreaking research and development.
Collaborations
Throughout his career, Michael has collaborated with esteemed colleagues, including Carl F. Perez and Robert F. Halenbeck. These partnerships have further propelled innovation in the biotechnology space, driving forward the research that has led to his numerous patents.
Conclusion
Michael Kriegler's work stands as a testament to the remarkable potential of innovative research in biotechnology. His contributions, particularly in the realm of recombinant proteins, are instrumental in shaping future medical therapies and providing solutions for health challenges. With a wealth of patents and collaborations, Michael continues to be a significant figure in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile